Drugs associated with vasculitis.
Newer agents of particular interest to rheumatologists are increasingly associated with vasculitis. There is now good evidence that treatment with hematopoietic growth factors, including granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor, can cause or mimic va...
| Publicado en: | Current Opinion in Rheumatology Vol. 10; no. 1; pp. 45 - 51 |
|---|---|
| Autor principal: | |
| Formato: | review Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
1998 Jan
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=138644674&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 138644674 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10408711 IR0 jtl: Current Opinion in Rheumatology issn: 10408711 maglogo: N pubinfo: dt: 1998 Jan vid: 10 iid: 1 pid: 433 pub: Lippincott Williams & Wilkins place: Baltimore, Maryland artinfo: ui: 138644674 138644674 NLM9448989 138644674 10.1097/00002281-199801000-00007 NLM9448989 138644674 ppf: 45 ppct: 6 formats: tig: atl: Drugs associated with vasculitis. aug: au: Merkel, P A affil: Arthritis Unit-Bulfinch 165, Massachusetts General Hospital, Boston 02114, USA sug: subj: Vasculitis Chemically Induced Adverse Drug Event Drugs Vasculitis Immunology Autoantibodies Immunology Scales ab: Newer agents of particular interest to rheumatologists are increasingly associated with vasculitis. There is now good evidence that treatment with hematopoietic growth factors, including granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor, can cause or mimic vasculitides such as Sweet's syndrome and pyoderma gangrenosum. Similarly, there is strong evidence that clinical use of interferons is associated with a variety of autoimmune phenomenon rarely including vasculitis. The increased availability of testing for antineutrophil cytoplasmic antibody (ANCA) has widened the clinical spectrum of systemic vasculitides. There are now many reports that treatment with either hydralazine or propylthiouracil is associated with ANCA-positive vasculitis. A small number of case reports also implicate penicillamine and minocycline as agents capable of inducing an ANCA-associated vasculitis. Clinicians should be aware of the potential of certain drugs to cause vasculitis and especially cautious in using these agents in patients with known vasculitis. pubtype: Academic Journal doctype: review Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|